Active Ingredient History
Streptokinase is a thrombolytic medication activating plasminogen by nonenzymatic mechanism. As a medication it is used to break down clots in some cases of myocardial infarction, pulmonary embolism, and arterial thromboembolism. The type of heart attack it is used in is an ST elevation myocardial infarction (STEMI). It is given by injection into a vein. Wikipedia
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Myocardial Infarction (approved 1977)
Acute Coronary Syndrome (Phase 4)
Bronchitis (Phase 4)
Cardiovascular Diseases (Phase 3)
Coronary Disease (Phase 3)
Heart Diseases (Phase 3)
Ischemic Stroke (Phase 2)
Myocardial Infarction (Phase 4)
Myocardial Ischemia (Phase 3)
Pancreatitis (Phase 2/Phase 3)
Pulmonary Embolism (Phase 4)
Reperfusion Injury (Phase 4)
Respiratory Distress Syndrome (Phase 3)
Respiratory Tract Infections (Phase 4)
Severe Acute Respiratory Syndrome (Phase 3)
Thrombosis (Phase 3)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
